Crossmark

Development and Evaluation of Chitosan-Safinamide Mesylate Nanoparticles for the Management of Parkinson’s Disease

Published Online: 2026-01-16

Authors

Sunkanna, Veena Kalyani

Joshi, Vedamurthy

Manjunath, Anoop
License Information

Text and Data Mining valid from 2026-01-16

Version of Record valid from 2026-01-16
More Information

Article History

Received: 21 February 2025

Accepted: 4 December 2025

First Online: 16 January 2026

Declarations

:

: Not Applicable.

: The authors declare no competing interests.

Document is current